An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

NCT02503176 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped Discontinuation of the development

Conditions

Dry Eye With Sjögren's Syndrome

Interventions

DRUG: KCT-0809 ophthalmic solution

Sponsor

Kissei Pharmaceutical Co., Ltd.